vs
R F INDUSTRIES LTD（RFIL）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是R F INDUSTRIES LTD的1.6倍（$35.5M vs $22.7M），R F INDUSTRIES LTD净利率更高（0.8% vs -304.2%，领先305.0%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 22.9%），R F INDUSTRIES LTD自由现金流更多（$2.0M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 29.8%）
妥思卷工业是一家总部位于美国伊利诺伊州芝加哥的糖果制造商，旗下最知名的产品包括同名的Tootsie Roll软糖以及Tootsie Pop棒棒糖，目前其品牌产品销往加拿大、墨西哥等全球超过75个国家。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
RFIL vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.6倍
$22.7M
营收增速更快
RXRX
高出658.8%
22.9%
净利率更高
RFIL
高出305.0%
-304.2%
自由现金流更多
RFIL
多$49.3M
$-47.3M
两年增速更快
RXRX
近两年复合增速
29.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $22.7M | $35.5M |
| 净利润 | $173.0K | $-108.1M |
| 毛利率 | 36.8% | 59.8% |
| 营业利润率 | 4.0% | -304.8% |
| 净利率 | 0.8% | -304.2% |
| 营收同比 | 22.9% | 681.7% |
| 净利润同比 | 172.7% | 39.6% |
| 每股收益（稀释后） | $0.01 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RFILRXRX
| Q4 25 | $22.7M | $35.5M | ||
| Q3 25 | $19.8M | $5.2M | ||
| Q2 25 | $18.9M | $19.2M | ||
| Q1 25 | $19.2M | $14.7M | ||
| Q4 24 | $18.5M | $4.5M | ||
| Q3 24 | $16.8M | $26.1M | ||
| Q2 24 | $16.1M | $14.4M | ||
| Q1 24 | $13.5M | $13.8M |
净利润RFILRXRX
| Q4 25 | $173.0K | $-108.1M | ||
| Q3 25 | $392.0K | $-162.3M | ||
| Q2 25 | $-245.0K | $-171.9M | ||
| Q1 25 | $-245.0K | $-202.5M | ||
| Q4 24 | $-238.0K | $-178.9M | ||
| Q3 24 | $-705.0K | $-95.8M | ||
| Q2 24 | $-4.3M | $-97.5M | ||
| Q1 24 | $-1.4M | $-91.4M |
毛利率RFILRXRX
| Q4 25 | 36.8% | 59.8% | ||
| Q3 25 | 34.0% | -183.8% | ||
| Q2 25 | 31.5% | -4.9% | ||
| Q1 25 | 29.8% | -48.0% | ||
| Q4 24 | 31.3% | -181.4% | ||
| Q3 24 | 29.5% | 53.7% | ||
| Q2 24 | 29.9% | 36.2% | ||
| Q1 24 | 24.5% | 19.1% |
营业利润率RFILRXRX
| Q4 25 | 4.0% | -304.8% | ||
| Q3 25 | 3.6% | -3327.6% | ||
| Q2 25 | 0.6% | -916.8% | ||
| Q1 25 | 0.3% | -1297.9% | ||
| Q4 24 | 0.5% | -4042.4% | ||
| Q3 24 | -2.5% | -377.1% | ||
| Q2 24 | -2.6% | -697.4% | ||
| Q1 24 | -15.5% | -698.4% |
净利率RFILRXRX
| Q4 25 | 0.8% | -304.2% | ||
| Q3 25 | 2.0% | -3135.3% | ||
| Q2 25 | -1.3% | -894.2% | ||
| Q1 25 | -1.3% | -1373.3% | ||
| Q4 24 | -1.3% | -3935.5% | ||
| Q3 24 | -4.2% | -367.5% | ||
| Q2 24 | -26.7% | -676.6% | ||
| Q1 24 | -10.1% | -662.4% |
每股收益（稀释后）RFILRXRX
| Q4 25 | $0.01 | $-0.17 | ||
| Q3 25 | $0.04 | $-0.36 | ||
| Q2 25 | $-0.02 | $-0.41 | ||
| Q1 25 | $-0.02 | $-0.50 | ||
| Q4 24 | $-0.02 | $-0.56 | ||
| Q3 24 | $-0.07 | $-0.34 | ||
| Q2 24 | $-0.41 | $-0.40 | ||
| Q1 24 | $-0.13 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.1M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $35.2M | $1.1B |
| 总资产 | $73.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资RFILRXRX
| Q4 25 | $5.1M | $743.3M | ||
| Q3 25 | $3.0M | $659.8M | ||
| Q2 25 | $3.6M | $525.1M | ||
| Q1 25 | $1.3M | $500.5M | ||
| Q4 24 | $839.0K | $594.4M | ||
| Q3 24 | $1.8M | $427.6M | ||
| Q2 24 | $1.4M | $474.3M | ||
| Q1 24 | $4.5M | $296.3M |
总债务RFILRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益RFILRXRX
| Q4 25 | $35.2M | $1.1B | ||
| Q3 25 | $34.8M | $1.0B | ||
| Q2 25 | $34.2M | $919.1M | ||
| Q1 25 | $34.2M | $933.9M | ||
| Q4 24 | $34.1M | $1.0B | ||
| Q3 24 | $34.1M | $524.6M | ||
| Q2 24 | $34.6M | $584.4M | ||
| Q1 24 | $38.7M | $401.2M |
总资产RFILRXRX
| Q4 25 | $73.0M | $1.5B | ||
| Q3 25 | $73.2M | $1.4B | ||
| Q2 25 | $72.7M | $1.3B | ||
| Q1 25 | $70.4M | $1.3B | ||
| Q4 24 | $71.0M | $1.4B | ||
| Q3 24 | $71.9M | $726.5M | ||
| Q2 24 | $72.8M | $775.9M | ||
| Q1 24 | $79.1M | $557.8M |
负债/权益比RFILRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.1M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $2.0M | $-47.3M |
| 自由现金流率自由现金流/营收 | 9.0% | -133.1% |
| 资本支出强度资本支出/营收 | 0.3% | 3.5% |
| 现金转化率经营现金流/净利润 | 12.13× | — |
| 过去12个月自由现金流最近4个季度 | $4.3M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流RFILRXRX
| Q4 25 | $2.1M | $-46.1M | ||
| Q3 25 | $-311.0K | $-117.4M | ||
| Q2 25 | $2.2M | $-76.4M | ||
| Q1 25 | $601.0K | $-132.0M | ||
| Q4 24 | $-244.0K | $-115.4M | ||
| Q3 24 | $2.4M | $-59.2M | ||
| Q2 24 | $197.0K | $-82.2M | ||
| Q1 24 | $840.0K | $-102.3M |
自由现金流RFILRXRX
| Q4 25 | $2.0M | $-47.3M | ||
| Q3 25 | $-419.0K | $-117.6M | ||
| Q2 25 | $2.2M | $-79.6M | ||
| Q1 25 | $574.0K | $-133.8M | ||
| Q4 24 | $-418.0K | $-116.7M | ||
| Q3 24 | $2.1M | $-63.8M | ||
| Q2 24 | $28.0K | $-83.4M | ||
| Q1 24 | $697.0K | $-109.0M |
自由现金流率RFILRXRX
| Q4 25 | 9.0% | -133.1% | ||
| Q3 25 | -2.1% | -2272.5% | ||
| Q2 25 | 11.4% | -413.9% | ||
| Q1 25 | 3.0% | -907.4% | ||
| Q4 24 | -2.3% | -2567.7% | ||
| Q3 24 | 12.6% | -244.6% | ||
| Q2 24 | 0.2% | -578.5% | ||
| Q1 24 | 5.2% | -789.9% |
资本支出强度RFILRXRX
| Q4 25 | 0.3% | 3.5% | ||
| Q3 25 | 0.5% | 4.7% | ||
| Q2 25 | 0.2% | 16.4% | ||
| Q1 25 | 0.1% | 12.4% | ||
| Q4 24 | 0.9% | 28.6% | ||
| Q3 24 | 1.5% | 17.5% | ||
| Q2 24 | 1.0% | 8.2% | ||
| Q1 24 | 1.1% | 48.2% |
现金转化率RFILRXRX
| Q4 25 | 12.13× | — | ||
| Q3 25 | -0.79× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
RXRX
暂无分部数据
